Gilead, Pfizer Execs Suggest Even More Pharma M&A Is on Way

(Bloomberg) -- U.S. drugmakers are showing a new appetite for deals after saying for months that they were focused mainly on existing products.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.